These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 9222045

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Nishino Y, Ishihara S, Kawada Y.
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
    Liu YH, Kuo SC, Lee YT, Chang IC, Yang SP, Chen TL, Fung CP.
    J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
    [Abstract] [Full Text] [Related]

  • 5. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis.
    Kanematsu E, Deguchi T, Yasuda M, Kawamura T, Nishino Y, Kawada Y.
    Antimicrob Agents Chemother; 1998 Feb; 42(2):433-5. PubMed ID: 9527801
    [Abstract] [Full Text] [Related]

  • 6. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii.
    Vila J, Ruiz J, Goñi P, Marcos A, Jimenez de Anta T.
    Antimicrob Agents Chemother; 1995 May; 39(5):1201-3. PubMed ID: 7625818
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro.
    Bébéar CM, Renaudin H, Charron A, Bové JM, Bébéar C, Renaudin J.
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2304-11. PubMed ID: 9736554
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
    Kumagai Y, Kato JI, Hoshino K, Akasaka T, Sato K, Ikeda H.
    Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598
    [Abstract] [Full Text] [Related]

  • 13. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
    Pan XS, Fisher LM.
    J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insertion sequence disruption of adeR and ciprofloxacin resistance caused by efflux pumps and gyrA and parC mutations in Acinetobacter baumannii.
    Lopes BS, Amyes SG.
    Int J Antimicrob Agents; 2013 Feb; 41(2):117-21. PubMed ID: 23217848
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci.
    González I, Georgiou M, Alcaide F, Balas D, Liñares J, de la Campa AG.
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2792-8. PubMed ID: 9797205
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.